Corpus ID: 36870090

Insulin therapy in type 2 diabetes : Initiation, impact on liver fat, role of combination therapy with glitazones or glindes

@inproceedings{Juurinen2014InsulinTI,
  title={Insulin therapy in type 2 diabetes : Initiation, impact on liver fat, role of combination therapy with glitazones or glindes},
  author={L. Juurinen},
  year={2014}
}
......................................................................................................................... 3 lIst of orIgInal publIcatIons ............................................................... 7 abbrevIatIons ................................................................................................. 8 
1 Citations
Actin regulation in dendritic spines: From synaptic plasticity to animal behavior and human neurodevelopmental disorders
33/2019 Inkeri Spoljaric GABAergic Signaling and Neuronal Chloride Regulation in the Control of Network Events in the Immature Hippocampus 34/2019 Nina Mars Healthcare Utilization in RheumaticExpand

References

SHOWING 1-10 OF 248 REFERENCES
Regulation of hepatic glucose metabolism in humans.
TLDR
Determinants of Net Splanchnic Glucose Balance: An Overview and Results are presented, which show the importance of Hepatic virsus Gastrointestinal Tissues, as well as the role of Hyperglycemia, in contributing to this balance. Expand
Rosiglitazone: safety and efficacy in combination with insulin in poorly controlled type 2 diabetes mellitus patients treated with insulin alone.
TLDR
Rosiglitazone+insulin combination is safe and effective in inadequately controlled insulin-treated T2DM patients and improved glycaemic control was associated with favourable reduction in cardiovascular risk factors. Expand
Effect of Insulin Versus Triple Oral Therapy on the Progression of Hepatic Steatosis in Type 2 Diabetes
TLDR
Improvements in HTC with initial insulin/metformin therapy persisted through the median 31-month follow-up period regardless of the treatment, and insulin-based treatment did not appear to promote or worsen nonalcoholic fatty liver disease. Expand
Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus.
TLDR
It is concluded that treatment with sulfonylureas or exogenous insulin results in equivalent improvement in insulin action in patients with non-insulin-dependent diabetes mellitus, and the choice between these agents should be based on considerations other than their ability to ameliorate insulin resistance. Expand
Response of Non-insulin-dependent Diabetic Patients to an Intensive Program of Diet and Exercise
TLDR
It is concluded that the Pritikin program of diet and exercise for treating patients with non-insulin-dependent diabetes mellitus is an effective means for treating NIDDM patients and that the high-complexcarbohydrate, high-fiber, low-fat diet is of primary importance. Expand
Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes.
TLDR
It is demonstrated that nateglinide selectively enhanced early insulin release and provided better mealtime glucose control with less total insulin exposure than glyburide. Expand
Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
TLDR
The results suggest that the direct effects of PIO on adipose tissue to decrease plasma FFA levels and increase plasma adiponectin contribute to the improvements in hepatic and peripheral insulin sensitivity and glucose tolerance in patients with T2DM. Expand
Low-dose rosiglitazone in patients with insulin-requiring type 2 diabetes.
TLDR
The addition of low-dose rosiglitazone to insulin therapy is an effective and well-tolerated treatment option for patients with type 2 diabetes mellitus who continue to have poor glycemic control despite administration of exogenous insulin as monotherapy. Expand
Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus
TLDR
Improved glycaemia promotes weight gain by decreasing both basal metabolic rate and glucosuria and is therefore a useful adjunct to insulin therapy in patients with Type II diabetes. Expand
Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.
TLDR
In patients with type 2 diabetes and coronary artery disease, liver fat content is a novel independent indicator of myocardial insulin resistance and reduced coronary functional capacity. Expand
...
1
2
3
4
5
...